Could a new class of drugs rebalance the body and prevent excessive inflammation?Paul Shapiro, PhD, professor at the University of Maryland School of Pharmacy and partner Jeffrey Hasday, MD, professor at the University of Maryland School of Medicine are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases. The secret is protein kinases, enzymes that regulate how various proteins interact and alter how they function.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #InflammationResearch #DrugDiscovery #ProteinKinase, #MedicalBreakthrough #ChronicInflammation #BiomedicalResearch #PharmaceuticalScience #TranslationalMedicine #UMBresearch #EnzymeTherapy #InflammationTreatment, #FutureOfMedicine #LifeSavingResearch, #HealthInnovation

Protein kinases help regulate inflammation — but what happens when their activity goes unchecked?At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are exploring how adjusting kinase activity may help reduce the severity of inflammation-related diseases.Watch how this breakthrough could lead to new strategies for improving long-term health. #ProteinKinases #HealthResearch #PharmacyInnovation #InflammationScience #MedicalBreakthrough #BreakthroughsCantWaitUMB